ABCIXIMAB

Indications & Dose:

Prevention of ischaemic cardiac complications in patients undergoing percutaneous coronary intervention (specialist use only)

• INITIALLY BY INTRAVENOUS INJECTION

Adult: Initially 250 micrograms/kg, to be given over 1 minute, then (by intravenous infusion)125 nanograms/kg/minute (max. per dose 10 micrograms/minute), to be started 10–60 minutes before percutaneous coronary intervention and continue for 12 hours

Short-term prevention of myocardial infarction in patients with unstable angina not responding to conventional treatment and who are scheduled for percutaneous coronary intervention (specialist use only)

• INITIALLY BY INTRAVENOUS INJECTION 

Adult: Initially 250 micrograms/kg, to be given over 1 minute, then (by intravenous infusion)125 nanograms/kg/minute (max. per dose 10 micrograms/minute), to be started up to 24 hours before possible percutaneous coronary intervention and continue infusion for 12 hours after intervention

Contraindications:

Side Effects:

Cautions:

Precautions:

Interaction:

Warnings:

Adverse Effects:

Lactations:

Special Precautions:

Counselling:

Side Effects Or Adverse Reactions:

Patient And Carer Advice: